Downloads

also available as a video with explanations on YouTube

* First patient enrolled at Hôpital Beaujon, Clichy, France; * The COMBAT Trial is a multicenter, randomized, open-label, Phase II clinical trial in patients with decompensated cirrhosis; Barcelona, Spain, 9th July 2024 – DECISION, an EU-funded research consortium in liver disease research, is pleased to announce the enrollment of the first patient at Hôpital Beaujon, Clichy, France in the COMBAT Trial, a multicenter, randomized, open-label, Phase II clinical trial. This trial is a crucial component of the DECISION project, which aims to transform the treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF). [More info on the document]